Mastering CTD Module 2.3: Automating the Quality Overall Summary (QOS) with AI

Aug 03, 2026

Discover how AuroraPrime RMA accelerates the CTD Module 2.3 Quality Overall Summary (QOS) creation. Eliminate manual data errors with AI.

image_20260708220748 Large.jpeg

Chemistry, Manufacturing, and Controls (CMC) teams face an unenviable task during a regulatory submission. They must synthesize thousands of pages of highly technical data into a concise, accurate narrative.

For many, this culminates in the creation of the CTD Module 2.3 Quality Overall Summary (QOS). Historically, this has meant endless hours of copying data tables and verifying source links. Today, with tools like AlphaLife Sciences's AuroraPrime RMA, pharmaceutical companies are discovering a far better way forward. By using an advanced AI Regulatory and Medical Authoring solution, you can drastically reduce the time spent on formatting and manual data transposition while ensuring absolute regulatory compliance.

The Bottleneck in CMC Automation

Creating a solid CTD Module 2.3 isn’t just about writing; it represents the critical synthesis of an exhaustive amount of information from Module 3 (Quality Documentation). When clinical teams rely on disconnected word processors and manual data pulls, several major bottlenecks emerge.

1. The Risk of Data Transposition Errors

Regulatory bodies, including the FDA and EMA, scrutinize CMC submissions for consistency. When a medical writer must manually move data points from a source PDF into the QOS, human error is inevitable. A single misplaced decimal in a drug substance specification can trigger regulatory queries that delay approvals by months.

2. Version Control Nightmares

During the late stages of a submission, manufacturing data often changes. As specifications update, keeping the QOS perfectly synced with Module 3 becomes a chaotic exercise in version control.

3. Time-Intensive Formatting

IRBs and regulatory reviewers expect a structured, consistent format. Achieving this perfectly styled output manually can consume up to 40% of a writer's time—time that should be spent on strategic narrative synthesis.

Solving the QOS Challenge with AuroraPrime RMA

An effective AI Writing Solution for Life Sciences doesn’t just generate text; it fundamentally reorganizes the authoring workflow. AuroraPrime RMA uses an AI Augmentation Strategy designed specifically to alleviate these CMC bottlenecks.

Seamless Veeva Vault RIM Integration

Because AuroraPrime RMA natively integrates with Veeva Vault RIM, your CTD Module 2.3 always references the approved, single source of truth. As source documents are updated in Veeva, the AI can seamlessly pull the most recent quantitative data into your QOS.

Intelligent Data Extraction and Structuring

Instead of manually typing out tables, the system’s AI directly extracts complex drug substance and drug product specifications from your raw reports. It structures this data precisely according to the rigid CTD hierarchy, eliminating transcription errors and guaranteeing data precision.

By integrating AI, CMC teams typically see a 70% reduction in manual formatting and a drastically smoother review cycle.

Frequently Asked Questions

Can AI completely write the CTD Module 2.3?

No. An AI platform like AuroraPrime RMA does the heavy lifting: extracting data, formatting tables, and drafting the initial structured narrative. Human CMC experts must review, refine, and contextualize the final summary.

Does AuroraPrime RMA comply with ICH guidelines?

Yes. The platform is built specifically for Life Sciences and structures all outputs in strict alignment with ICH M4Q guidelines for Module 2.3.

How does this affect regulatory review times?

By eliminating simple data inconsistencies and transposition errors, the QOS is submitted with higher accuracy, which often leads to fewer review queries and faster clearance.

Conclusion

The shift toward CMC Automation is no longer just a futuristic concept; it is an active necessity for competitive life science organizations. The CTD Module 2.3 Quality Overall Summary (QOS) is a prime candidate for technological transformation.

By implementing an AI Regulatory and Medical Authoring solution like AuroraPrime RMA, your CMC and medical writing teams can stop acting as data transcribers and start focusing on strategic submission enablement.

Ready to eliminate formatting bottlenecks and reduce your CMC writing time?

**Read more and transform your authoring workflow: https://alphalifesci.com/contact-us**